FAM84A antibody (AA 15-144) (FITC)
Quick Overview for FAM84A antibody (AA 15-144) (FITC) (ABIN7165576)
Target
See all FAM84A AntibodiesReactivity
Host
Clonality
Conjugate
Application
- 
    - 
                                            Binding Specificity
- AA 15-144
- 
                                            Cross-Reactivity
- Human
- 
                                            Purification
- >95%, Protein G purified
- 
                                            Immunogen
- Recombinant Human Protein FAM84A protein (15-144AA)
- 
                                            Isotype
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            Restrictions
- For Research Use only
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Buffer
- 
                        Preservative: 0.03 % Proclin 300
 Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4
- 
                                            Preservative
- ProClin
- 
                                            Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            Storage
- -20 °C,-80 °C
- 
                                            Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
 
- 
                                            
- 
    - FAM84A (Family with Sequence Similarity 84, Member A (FAM84A))
- 
                                            Alternative Name
- FAM84A
- 
                                            Background
- LRATD1 antibody, FAM84A antibody, NSE1 antibody, Protein LRATD1 antibody, LRAT domain-containing 1 antibody, Neurologic sensory protein 1 antibody, NSE1 antibody, Protein FAM84A antibody
- 
                                            UniProt
- Q96KN4
 Target
- 
                    
 
                                     
                                     
                                    